Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
NCT06905054Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Apr 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenofibrate in Primary Sclerosing Cholangitis (PSC), sponsored by Mayo Clinic. Started Apr 2025; status: recruiting.
02
Drugs
fenofibrate
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT06905054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905054.